Literature DB >> 25002294

Elevation of soluble intercellular adhesion molecule-1 levels, but not angiopoietin 2, in the plasma of human immunodeficiency virus-infected African women with clinical Kaposi sarcoma.

Susan M Graham1, Nimerta Rajwans2, Barbra A Richardson2, Walter Jaoko2, R Scott McClelland2, Julie Overbaugh2, W Conrad Liles2.   

Abstract

Circulating levels of endothelial activation biomarkers are elevated in during infection with human immunodeficiency virus 1 (HIV-1) and may also be increased in Kaposi sarcoma (KS). We compared 23 HIV-1-seropositive women with clinically diagnosed KS with 46 randomly selected controls matched for visit year, CD4 count, and antiretroviral therapy status. Conditional logistic regression was used to identify differences between cases and controls. The odds of clinical KS increased with increasing plasma viral load and with intercellular adhesion molecule 1 (ICAM-1) levels above or equal to the median. There was a borderline association between increasing plasma angiopoietin 2 levels and KS. In multivariable modeling including plasma viral load, angiopoietin 2, and ICAM-1, plasma ICAM-1 levels above or equal to the median remained associated with clinical KS (odds ratio = 14.2, 95% confidence interval = 2.3-87.7). Circulating ICAM-1 levels should be evaluated as a potential biomarker for disease progression and treatment response among HIV-infected KS patients. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25002294      PMCID: PMC4183391          DOI: 10.4269/ajtmh.14-0209

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  23 in total

1.  Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis.

Authors:  S Pati; M Cavrois; H G Guo; J S Foulke; J Kim; R A Feldman; M Reitz
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

2.  Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma.

Authors:  L F Brown; B J Dezube; K Tognazzi; H F Dvorak; G D Yancopoulos
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

3.  [The histogenesis of Kaposi sarcoma: a histochemical and electronmicroscopical study (author's transl)].

Authors:  O Braun-Falco; C Schmoeckel; G Hübner
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-02-16

4.  CD8(+)CD28(-) T lymphocytes from HIV-1-infected patients secrete factors that induce endothelial cell proliferation and acquisition of Kaposi's sarcoma cell features.

Authors:  Giulio Alessandri; Simona Fiorentini; Stefano Licenziati; Monica Bonafede; Paolo Monini; Barbara Ensoli; Arnaldo Caruso
Journal:  J Interferon Cytokine Res       Date:  2003-09       Impact factor: 2.607

5.  Cultured Kaposi's sarcoma cell lines express factor XIIIa, CD14, and VCAM-1, but not factor VIII or ELAM-1.

Authors:  Y Q Huang; A E Friedman-Kien; J J Li; B J Nickoloff
Journal:  Arch Dermatol       Date:  1993-10

6.  Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma.

Authors:  Hsei-Wei Wang; Matthew W B Trotter; Dimitrios Lagos; Dimitra Bourboulia; Stephen Henderson; Taija Mäkinen; Stephen Elliman; Adrienne M Flanagan; Kari Alitalo; Chris Boshoff
Journal:  Nat Genet       Date:  2004-06-27       Impact factor: 38.330

7.  Serum levels of intercellular adhesion molecule 1 in patients with HIV-related Kaposi's sarcoma.

Authors:  P De Paoli; C Caffau; M D'Andrea; M Tavio; U Tirelli; G Santini
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-07

8.  Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells.

Authors:  S Uccini; L P Ruco; F Monardo; A Stoppacciaro; E Dejana; I L La Parola; D Cerimele; C D Baroni
Journal:  J Pathol       Date:  1994-05       Impact factor: 7.996

9.  A prospective study of endothelial activation biomarkers, including plasma angiopoietin-1 and angiopoietin-2, in Kenyan women initiating antiretroviral therapy.

Authors:  Susan M Graham; Nimerta Rajwans; Kenneth A Tapia; Walter Jaoko; Benson B A Estambale; R Scott McClelland; Julie Overbaugh; W Conrad Liles
Journal:  BMC Infect Dis       Date:  2013-06-04       Impact factor: 3.090

10.  Kaposi's sarcoma in Uganda: geographic and ethnic distribution.

Authors:  J F Taylor; P G Smith; D Bull; M C Pike
Journal:  Br J Cancer       Date:  1972-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.